Ganciclovir and Joint swelling - a phase IV clinical study of FDA data

Summary:

Joint swelling is reported as a side effect among people who take Ganciclovir (ganciclovir), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rinvoq, and have Crohn's disease.

The phase IV clinical study analyzes which people have Joint swelling when taking Ganciclovir. It is created by eHealthMe based on reports of 6,363 people who have side effects when taking Ganciclovir from the FDA, and is updated regularly.

What is Ganciclovir?

Ganciclovir has active ingredients of ganciclovir. eHealthMe is studying from 6,370 Ganciclovir users. Check the latest studies of Ganciclovir.

What is Joint swelling?

Joint swelling is found to be associated with 2,122 drugs and 2,940 conditions by eHealthMe. Check the latest studies of Joint swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,363 people reported to have side effects when taking Ganciclovir.
Among them, 13 people (0.2%) have Joint swelling.

Among these 13 people:

How long have people been on Ganciclovir when they have Joint swelling? *

What is the gender of people who have Joint swelling when taking Ganciclovir? *

female: 20 %
male: 80 %

What is the age of people who have Joint swelling when taking Ganciclovir? *

What are other drugs people take besides Ganciclovir? *

Prednisolone: 5 people, 38.46%
Rinvoq: 5 people, 38.46%
Fluconazole: 4 people, 30.77%
Sertraline: 3 people, 23.08%
Metformin Hydrochloride: 3 people, 23.08%
Lisinopril: 3 people, 23.08%
Oxycodone Hydrochloride: 3 people, 23.08%
Oxycontin: 3 people, 23.08%
Gabapentin: 3 people, 23.08%
Potassium: 3 people, 23.08%

What are other side effects people have besides Joint swelling? *

Joint Pain: 7 people, 53.85%
Pneumonia: 6 people, 46.15%
Joint Stiffness: 5 people, 38.46%
Respiratory Tract Infection: 5 people, 38.46%
Dyspnea (difficult or laboured breathing): 5 people, 38.46%
General Physical Health Deterioration (weak health status): 5 people, 38.46%
Rashes (redness): 4 people, 30.77%
Subileus: 4 people, 30.77%
Pain In Extremity: 4 people, 30.77%
Muscle Aches (muscle pain): 4 people, 30.77%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 46.15%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 23.08%
Cytomegalovirus Infection: 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Sedation: 1 person, 7.69%
Gastric Ulcer (stomach ulcer): 1 person, 7.69%
Bacterial Infection: 1 person, 7.69%
Constipation: 1 person, 7.69%
Depression: 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ganciclovir and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ganciclovir:

Ganciclovir (6,370 reports)

Joint swelling treatments and more:

Joint swelling (143,797 reports)

Browse all side effects of Ganciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint swelling:

Joint swelling (2,122 drugs)

Browse all the conditions that are associated with Joint swelling:

Joint swelling (2,940 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ganciclovir (the active ingredients of Ganciclovir) and Ganciclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.